Andrew Hill Investment Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.14M Buy
39,795
+3,160
+9% +$269K 2.33% 20
2026
Q1
$3.16M Sell
36,635
-4,653
-11% -$418K 2.81% 14
2025
Q4
$3.6M Buy
+41,288
New +$3.13M 2.75% 15

Other funds holding GMED

Andrew Hill Investment Advisors's GMED Position: Q2 2026 in Review

Andrew Hill Investment Advisors increased its Globus Medical (GMED) stake by 8.6% in Q2 2026, buying an estimated $269K and bringing the position to 39,795 shares worth $3.14M. The position accounts for 2.33% of the portfolio, ranked #20.

Andrew Hill Investment Advisors first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.6M in Q4 2025. 167 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Andrew Hill Investment Advisors held 39,795 shares of Globus Medical worth $3.14M as of Q2 2026.
  • Andrew Hill Investment Advisors bought 3,160 Globus Medical shares in Q2 2026, an estimated $269K.
  • Globus Medical made up 2.33% of Andrew Hill Investment Advisors's portfolio in Q2 2026, its #20 holding.
  • Andrew Hill Investment Advisors first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Andrew Hill Investment Advisors's Globus Medical position peaked at $3.6M in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Andrew Hill Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.